Should You Hold ORIC Pharmaceuticals Inc (ORIC) Stock Monday Morning?

ORIC Pharmaceuticals Inc (ORIC) is higher by Monday morning, with the stock rising 12.90% in pre-market trading to 6.39. ORIC's short-term technical score of 67 indicates that the stock has traded more bullishly over the last month than 67% of stocks on the market. In the Biotechnology industry, which ranks 137 out of 146 industries, the stock ranks higher than 84% of stocks. ORIC Pharmaceuticals Inc has fallen 27.53% over the past month, closing at $7.56 on September 25. During this period of time, the stock fell as low as $5.41 and as high as $8.02. ORIC has an average analyst recommendation of Strong Buy. The company has an average price target of $15.63.

ORIC has an Overall Score of 71. Find out what this means to you and get the rest of the rankings on ORIC!

See Full ORIC Report

ORIC Pharmaceuticals Inc has a Long-Term Technical rank of 77. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 23% of the market scoring higher. In the Biotechnology industry which is number 135 by this metric, ORIC ranks better than 135% of stocks.

Important Dates for Investors in ORIC:

-ORIC Pharmaceuticals Inc is set to release earnings on 2023-11-06. Over the last 12 months, the company has reported EPS of $-2.18. -We do not have a set dividend date for ORIC Pharmaceuticals Inc at this time. Click Here To Get The Full Report on ORIC Pharmaceuticals Inc (ORIC)